Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry.

By G. Pauletti, Suganda Dandekar, H. Rong, Lilllian Ramos, Hongjun Peng, Ram Seshadri, D. Slamon. Journal of Clinical Oncology, 2000

704 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/498c9845531d025a6641371a9d1eee58b079abab

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. G. Hortobagyi

Citations in the corpus

• The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. (2009, background): “58 Kakar et al. (2000) [68] 117 Paraffin FISH, IHC FISH, 19; IHC, 28 Yes Not done Not given IHC 3 positive and FISH-positive cases correlated with outcome; IHC 2 positive cases did not 59 Agrup et al.”